De Novo vs. Acquisition: Which Growth Strategy Wins in 2026?

Healthcare MSOs looking to expand are often faced with a key decision. Should they build new locations from the ground up, or acquire existing ones? Both strategies can drive growth, but each comes with trade-offs that become more important as organizations scale.

De novo growth offers control. Organizations can choose the location, design the patient experience, hire the right team, and implement new systems from day one. This often leads to better alignment across operations, marketing, and patient experience. Over time, de novo locations can outperform acquired sites because they are built on a consistent foundation. The downside is speed. It takes time and capital to build awareness, generate demand, and reach stable patient volume.

Acquisitions offer the opposite advantage. They provide immediate access to an existing patient base, staff, and infrastructure. This can accelerate market entry and create faster short-term growth. However, integration is where many organizations struggle. Different systems, inconsistent workflows, and cultural differences can create friction. Without a clear plan, acquisitions can lead to uneven performance across locations.

Operational efficiency is where the gap between these strategies becomes more visible. In a de novo model, efficiency is designed upfront. Organizations can standardize scheduling templates, staffing ratios, intake workflows, and marketing attribution from day one. There is no need to unwind legacy processes or retrain teams with deeply ingrained habits. Technology stacks can be consistent across locations, which makes reporting cleaner and performance KPIs more visible to practice leaders. As a result, de novo sites often reach operational maturity with fewer variables, even if it takes longer to ramp patient volume.

In an acquisition model, efficiency is achieved over time. Each practice brand/location may come with its own EHR, billing processes, call handling, and local marketing approach, and it will take time to consolidate all of those systems within the broader portfolio, not to mention the people side of navigating change. Even small differences can create gaps in conversion rates, patient experience, and revenue cycle performance. For example, one site may convert inbound calls at a high rate due to strong front desk training, while another may struggle due to inconsistent scripting or slower follow-up. These variations are not always visible in top-line numbers but have a real impact on profitability.

This is why post-acquisition integration is an operational reset. High-performing organizations prioritize a clear integration roadmap that focuses on a few key areas: scheduling and intake, call center performance, payer mix optimization, and marketing initiatives (which ideally rolls up into one broader function). The goal is not to force immediate uniformity, but to move each site toward a shared operating model in a structured way.

In 2026, the most effective operators are not choosing one strategy over the other. They are combining both in a structured way. Acquisitions are used to enter new markets quickly or gain density in existing ones. De novo locations are used to expand within those markets and maintain control over execution.

The organizations that scale successfully treat operational efficiency as an ongoing strategy, not a one-time fix. They define what “good” looks like across key metrics like patient acquisition cost, call conversion rate, provider utilization, and time to first visit. Then they build playbooks that can be applied across both new and acquired sites.

Without that consistency, growth creates complexity regardless of how its achieved. With it, both strategies become scalable.